መነሻNOVN • SWX
add
Novartis AG
የቀዳሚ መዝጊያ
CHF 91.56
የቀን ክልል
CHF 92.04 - CHF 93.99
የዓመት ክልል
CHF 83.63 - CHF 102.72
የገበያው አጠቃላይ ዋጋ
205.76 ቢ CHF
አማካይ መጠን
2.97 ሚ
የዋጋ/ገቢ ምጥጥን
12.39
የትርፍ ክፍያ
3.52%
ዋና ልውውጥ
SWX
ዜና ላይ
ፋይናንስ
የገቢ መግለጫ
ገቢ
የተጣራ ገቢ
(USD) | ሴፕቴ 2024info | ከዓመት ዓመት ለውጥ |
---|---|---|
ገቢ | 13.17 ቢ | 8.93% |
የሥራ ወጪ | 5.52 ቢ | -24.45% |
የተጣራ ገቢ | 3.19 ቢ | 81.09% |
የተጣራ የትርፍ ክልል | 24.21 | 66.28% |
ገቢ በሼር | 2.06 | 18.39% |
EBITDA | 5.50 ቢ | 88.62% |
ውጤታማ የግብር ተመን | 5.91% | — |
ቀሪ ሒሳብ ሉሆች
አጠቃላይ ንብረቶች
አጠቃላይ ተጠያቂነቶች
(USD) | ሴፕቴ 2024info | ከዓመት ዓመት ለውጥ |
---|---|---|
ጥሬ ገንዘብና የአጭር ጊዜ መዋዕለ ንዋይ | 13.85 ቢ | 8.08% |
አጠቃላይ ንብረቶች | 103.52 ቢ | -8.14% |
አጠቃላይ ተጠያቂነቶች | 60.08 ቢ | -19.30% |
አጠቃላይ እሴት | 43.44 ቢ | — |
የሼሮቹ ብዛት | 2.00 ቢ | — |
የገበያ ዋጋ እና የተገለጸ ዋጋ | 4.23 | — |
የእሴቶች ተመላሽ | 10.97% | — |
የካፒታል ተመላሽ | 15.05% | — |
የገንዘብ ፍሰት
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ
(USD) | ሴፕቴ 2024info | ከዓመት ዓመት ለውጥ |
---|---|---|
የተጣራ ገቢ | 3.19 ቢ | 81.09% |
ከክወናዎች የተገኘ ጥሬ ገንዘብ | 6.29 ቢ | 16.88% |
ገንዘብ ከኢንቨስትመንት | -374.00 ሚ | 83.09% |
ገንዘብ ከፋይናንስ | -382.00 ሚ | 54.09% |
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ | 5.71 ቢ | 275.39% |
ነፃ የገንዘብ ፍሰት | 4.55 ቢ | -63.57% |
ስለ
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, “novae artes”.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
ዋና ሥራ አስፈጻሚ
የተመሰረተው
29 ፌብ 1996
ዋና መሥሪያ ቤት
ድህረገፅ
ሠራተኞች
76,057